Venova Medical recently announced the enrollment of the first patients in the company’s VENOS-2 early feasibility study o ...

Alan Lumsden, MD Walter W. Fondren III Presidential Distinguished Chair, DeBakey Heart & Vascular Center Chair, Department of ...

Dr. Suresh Vedantham asks Drs. Pavan Kavali and Kristen Sanfilippo about possible benefits of a DVT response team model, ...

In a large, real-world analysis of United States Medicare fee-for-service patients, Ferro et al found that inferior vena cava ...

The VIVA Foundation, in collaboration with representatives from the American Venous Forum (AVF) and American Vein and ...

Moderator Suresh Vedantham, MD, asks Leslie Lake, Volunteer President of the National Blood Clot Alliance and bilateral PE ...

Concept Medical Inc. announced the completion of patient enrollment in the SirPAD trial of the company’s MagicTouch percu ...

Insights into the digital tools that can help improve patient engagement and advance understanding in deep vein thrombosis ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, ...

Materials, characteristics, and approaches for use. Currently used embolic agents for PAE include polyvinyl alcohol (PVA) particles (Bearing nsPVA, Merit Medical Systems, Inc.; Contour, Boston ...

Gore & Associates announced the recent CE Mark approval of a lower-profile Gore Viabahn VBX balloon expandable endoprosthes ...

Cancer. Few words strike the fear and anxiety that cancer does. However, the field of oncology has undergone tremendous advances with respect to the medical, surgical, and radiation treatments that ...